ARTICLE I DEFINITIONS ----------- 1.1 General. As used in this Agreement and the Exhibits hereto, the ------- following terms shall have the following meanings:Distribution Agreement • December 27th, 1995 • Igi Inc • Biological products, (no disgnostic substances) • Delaware
------------------------------------------------------------------------------- - SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ---------------- FORM 10/A AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM 10 GENERAL FORM FOR REGISTRATION OF...Registration Statement • December 27th, 1995 • Igi Inc • Biological products, (no disgnostic substances)
NO PERSON IS AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATION OTHER THAN THOSE CONTAINED IN THIS INFORMATION STATEMENT, AND IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATIONS MUST BE RELIED UPON AS HAVING BEEN AUTHORIZED. THIS INFORMATION STATEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF ANY OFFER TO BUY ANY SECURITIES. THIS INFORMATION STATEMENT PRESENTS INFORMATION CONCERNING NOVAVAX, INC. BELIEVED BY NOVAVAX, INC. TO BE ACCURATE AS OF THE DATE SET FORTH ON THE COVER HEREOF. THIS INFORMATION STATEMENT ALSO PRESENTS INFORMATION CONCERNING IGI, INC. BELIEVED BY IGI, INC. TO BE ACCURATE AS OF THE DATE SET FORTH ON THE COVER HEREOF. CHANGES MAY OCCUR IN THE PRESENTED INFORMATION AFTER THAT DATE. NEITHER NOVAVAX, INC. NOR IGI, INC. PLANS TO UPDATE SAID INFORMATION EXCEPT IN THE COURSE OF FULFILLING THEIR RESPECTIVE NORMAL PUBLIC REPORTING AND DISCLOSURE OBLIGATIONS. TABLE OF CONTENTS
